Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Fraser

Showing results (541-550 of 598) with videos related to

Pageof 60
Sort By:
Journal of the National Cancer Institute|November 9, 2013
An international Ki67 reproducibility studyMei-Yin C Polley, Samuel C Y Leung, Lisa M McShane, et al.
Clinical Proteomics|September 13, 2011
Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancerAna M Gonzalez-Angulo, Bryan T Hennessy, Funda Meric-Bernstam, et al.
Cancer Research|August 5, 2008
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancerKatherine Stemke-Hale, Ana Maria Gonzalez-Angulo, Ana Lluch, et al.
Scientific Reports|October 22, 2020
Pharmacologic profiling of patient-derived xenograft models of primary treatment-naïve triple-negative breast cancerReid T Powell, Abena Redwood, Xuan Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Histology-Derived Signatures Predict Recurrence Risk and Chemotherapy Benefit in Randomized Trials of Early Breast CancerFrederick M Howard, Anran Li, Sara Kochanny, et al.
NPJ Breast Cancer|November 12, 2021
Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightnessOtto Metzger-Filho, Katharine Collier, Sarah Asad, et al.
Archives of Pathology & Laboratory Medicine|January 14, 2020
Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline UpdateKimberly H Allison, M Elizabeth H Hammond, Mitchell Dowsett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2020
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline UpdateKimberly H Allison, M Elizabeth H Hammond, Mitchell Dowsett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2025
Novel Postneoadjuvant Prognostic Breast Cancer Staging SystemDavid J Winchester, Lavisha Singh, Stephen B Edge, et al.
NPJ Breast Cancer|June 25, 2019
SET<sub>ER/PR</sub>: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancerBruno V Sinn, Chunxiao Fu, Rosanna Lau, et al.
Pageof 60

Showing results (541-550 of 598) with videos related to

Sort By:
Pageof 60
Journal of the National Cancer Institute|November 9, 2013
An international Ki67 reproducibility studyMei-Yin C Polley, Samuel C Y Leung, Lisa M McShane, et al.
Clinical Proteomics|September 13, 2011
Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancerAna M Gonzalez-Angulo, Bryan T Hennessy, Funda Meric-Bernstam, et al.
Cancer Research|August 5, 2008
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancerKatherine Stemke-Hale, Ana Maria Gonzalez-Angulo, Ana Lluch, et al.
Scientific Reports|October 22, 2020
Pharmacologic profiling of patient-derived xenograft models of primary treatment-naïve triple-negative breast cancerReid T Powell, Abena Redwood, Xuan Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Histology-Derived Signatures Predict Recurrence Risk and Chemotherapy Benefit in Randomized Trials of Early Breast CancerFrederick M Howard, Anran Li, Sara Kochanny, et al.
NPJ Breast Cancer|November 12, 2021
Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightnessOtto Metzger-Filho, Katharine Collier, Sarah Asad, et al.
Archives of Pathology & Laboratory Medicine|January 14, 2020
Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline UpdateKimberly H Allison, M Elizabeth H Hammond, Mitchell Dowsett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2020
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline UpdateKimberly H Allison, M Elizabeth H Hammond, Mitchell Dowsett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2025
Novel Postneoadjuvant Prognostic Breast Cancer Staging SystemDavid J Winchester, Lavisha Singh, Stephen B Edge, et al.
NPJ Breast Cancer|June 25, 2019
SET<sub>ER/PR</sub>: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancerBruno V Sinn, Chunxiao Fu, Rosanna Lau, et al.
Pageof 60